세계의 원격의료 및 원격 진료용 AI 시장 예측(-2030년) : 컴포넌트(소프트웨어, 서비스), 기능(가상 케어, 챗봇, RPM, 관리자, 환자 참여), 용도(원격 신경 진료, 원격 ICU, 원격 방사선 진단), 최종사용자별(의료 제공자, 보험자)

The global AI in telehealth & telemedicine market is projected to grow at a CAGR of 36.4% between 2024 and 2030. The AI in telehealth & telemedicine market is rapidly expanding due to various factors such as advancements in telecommunication technologies, favorable government support and regulatory policies, and the expansion of RPM systems. An increase in the geriatric population necessitates the continuous monitoring of chronic conditions, creating a growing demand for cost-effective healthcare solutions.

An increasing focus on the diagnosis of chronic illnesses such as diabetes and heart disease has led to an increased need for telehealth devices. AI technologies such as virtual assistants, predictive analytics, and automated note-taking help improve the effectiveness and availability of telehealth services. For instance, in March 2025, Eli Lilly and Company (US) introduced LillyDirect remote consultations to diagnose and treat Alzheimer's. Telehealth devices solve problems such as a lack of specialists and patient wait times, improving healthcare and patient access to advanced medical solutions.

The software segment is expected to have the fastest growth rate in the AI in telehealth market during the forecast period, by component.

By component, the software segment is expected to be the fastest growing market during the forecast period. Companies have promoted telehealth software due to the need for less capital for infrastructural development. Advanced software platforms enhanced with AI and ML have predictive analytics, personalization, and tailored care strategies, which also help companies promote telehealth solutions. Companies such as Cisco Systems, Inc. (US) offer Cisco HealthPresence 2.5 software solutions. Additionally, in February 2025, Teladoc Health Inc. (US) acquired Catapult Health (US), a provider of virtual preventive care solutions, for USD 65 million; this acquisition supports Teladoc Health Inc. in strengthening its market position.

The healthcare providers segment accounted for the largest market share in 2023.

On the basis of end users, the healthcare providers segment accounted for the largest market share in 2023. RPM, AI, and cloud systems allow for the personalization and timely delivery of healthcare services, which helps manage the increasing adoption of remote consultations and chronic disease management. Many healthcare facilities have adopted the telehealth platform to reduce waiting periods and can handle large patient pools with less administrative workflow. For instance, Mercy Health (US) offers Mercy Virtual Care Services, serving over 600,000 patients across seven US states with more than 300 clinicians, delivering care through advanced technologies such as two-way video, online-enabled instruments, and real-time vital sign monitoring. The program enhances patient access and outcomes while reducing healthcare costs by enabling earlier interventions and continuous remote monitoring for those with chronic or complex conditions.

The Asia Pacific is estimated to register the fastest CAGR during the forecast period.

The AI in telemedicine market is geographically segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is projected to register the fastest CAGR during the forecast period as it benefits from the fast-developing healthcare infrastructure and technological advancements. In addition, the rising use of digital healthcare products, growing healthcare needs resulting from large geriatric populations, and an increasing incidence of chronic diseases drive regional growth. Government initiatives also promote market growth. In February 2024, South Korea's health ministry announced it would fully allow telemedicine services at all hospitals and clinics. In addition, India offers universal health coverage through the national telemedicine service (eSanjeevani), which covers 130 specialties. The platform has created 17,084 telemedicine hubs and serviced 364,497,645 patients to date. Government initiatives promoting telemedicine and improvements in digital health infrastructure also contributed to market growth.

Breakdown of supply-side primary interviews by company type, designation, and region:

• By Company Type: Tier 1 (40%), Tier 2 (35%), and Tier 3 (25%)
• By Designation: Managers (40%), Directors (35%), and Other Designations (25%)
• By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%), and Middle East & Africa (2%)

List of Companies Profiled in the Report:

• 1. Koninklijke Philips N.V. (Netherlands)
• 2. Medtronic (Ireland)
• 3. GE Healthcare (US)
• 4. Epic Systems Corporation (US)
• 5. Oracle (US)
• 6. Doximity, Inc. (US)
• 7. Teladoc Health, Inc. (US)
• 8. American Well (US)
• 9. Siemens Healthineers AG (Germany)
• 10. Cisco Systems Inc. (US)
• 11. Included Health, Inc. (US)
• 12. AMC Health (US)
• 13. TeleSpecialists (US)
• 14. Walgreen Co. (US)
• 15. Caregility (US)
• 16. CVS Health (US)
• 17. AliveCor, Inc. (US)
• 18. Elation (US)
• 19. HealthTap, Inc. (US)
• 20. ZoomCommunications, Inc. (US)

Research Coverage:

This research report categorizes the AI in telehealth & telemedicine market by component [hardware, software {(by modality: EHR-centric, Non-EHR-centric), (by integration type: integrated software, standalone software), (by deployment: on-premise deployment, cloud-based deployment)}, and services], by function [virtual care consultations, chatbots & virtual assistants, remote patient monitoring, virtual nursing care platform, clinical documentation, administrative workflows, analytics & reporting, patient engagement, and other functions[, by application [primary care, speciality care {teleradiology, telecardiology, teleneurology, diabetes, respiratory disorders, hypertension, teledermatology, telepsychiatry, other specialty care applications}, teleICU, and other applications], by end user [healthcare providers {hospitals; ambulatory surgery centers, ambulatory care centers, and other outpatient settings; long-term care & assisted living facilities; home healthcare; and other healthcare providers}, healthcare payers, patients, pharmaceutical & biotechnology companies, medtech companies, and other end users], and region. The report's scope covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the AI in telehealth & telemedicine market. A thorough analysis of the key industry players has provided insights into their business overview, offerings, and key strategies, such as acquisitions, collaborations, partnerships, mergers, product/service launches & enhancements, and approvals in the AI in telehealth & telemedicine market. This report covers the competitive analysis of upcoming startups in the AI in telehealth & telemedicine market ecosystem.

Reasons to Buy the Report

The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall AI in telehealth and telemedicine market and its subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers: (increasing adoption of virtual assistant chatbots, rising popularity of e-prescriptions, growing adoption of EHRs in healthcare settings, advancements in digital health technologies, and shortage of skilled healthcare professionals), restraints (Regulatory variations across regions and lack of advanced telemedicine infrastructure in emerging economies), opportunities (growing popularity of virtual healthcare solutions, emergence of AI and ML, favorable government initiatives and reimbursement policies, rising focus on home healthcare, and expansion of remote patient monitoring markets), and challenges (Increasing data breaches and medical identity theft cases and complexities of big data in healthcare) influencing the growth of the AI in telehealth & telemedicine market.
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product & service launches in the AI in telehealth & telemedicine market.
• Market Development: Comprehensive information about lucrative markets-the report analyses the AI in telehealth & telemedicine market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the AI in telehealth & telemedicine market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Epic Systems Corporation (US), Oracle (US), Doximity, Inc. (US), and Teladoc Health, Inc. (US), among others

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 TELEHEALTH
  • 1.2.2 TELEMEDICINE
• 1.3 STUDY SCOPE
  • 1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key sources for secondary data
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key sources for primary data
    • 2.1.2.2 Key objectives of primary research
    • 2.1.2.3 Key data from primary sources
    • 2.1.2.4 Insights from primary experts
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 STUDY ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6.2 SCOPE-RELATED LIMITATIONS
• 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 AI IN TELEHEALTH & TELEMEDICINE MARKET OVERVIEW
• 4.2 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT AND COUNTRY
• 4.3 AI IN TELEHEALTH & TELEMEDICINE MARKET: GEOGRAPHIC SNAPSHOT
• 4.4 AI IN TELEHEALTH & TELEMEDICINE MARKET: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing adoption of virtual assistant chatbots
    • 5.2.1.2 Rising popularity of e-prescriptions
    • 5.2.1.3 Growing adoption of EHRs in healthcare settings
    • 5.2.1.4 Advancements in digital health technologies
    • 5.2.1.5 Shortage of skilled healthcare professionals
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Regulatory variations across regions
    • 5.2.2.2 Lack of advanced telemedicine infrastructure in emerging economies
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growing popularity of virtual healthcare solutions
    • 5.2.3.2 Emergence of AI and ML
    • 5.2.3.3 Favorable government initiatives and reimbursement policies
    • 5.2.3.4 Rising focus on home healthcare
    • 5.2.3.5 Expansion of remote patient monitoring markets
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Increasing data breaches and medical identity theft cases
    • 5.2.4.2 Complexities of big data in healthcare
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• 5.4 INDUSTRY TRENDS
  • 5.4.1 GEN AI FOR MEDICAL DOCUMENTATION
  • 5.4.2 INNOVATIONS IN REMOTE PATIENT MONITORING DEVICES
• 5.5 ECOSYSTEM ANALYSIS
  • 5.5.1 ROLE IN ECOSYSTEM
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 TECHNOLOGY ANALYSIS
  • 5.7.1 KEY TECHNOLOGIES
    • 5.7.1.1 Video conferencing and real-time communication platforms
    • 5.7.1.2 Virtual assistants and chatbots
    • 5.7.1.3 Voice recognition and natural language processing
    • 5.7.1.4 EHR integration
    • 5.7.1.5 Remote patient monitoring systems
  • 5.7.2 COMPLEMENTARY TECHNOLOGIES
    • 5.7.2.1 Cloud computing
    • 5.7.2.2 mHealth applications
    • 5.7.2.3 Wearable devices, sensors, and IoT
  • 5.7.3 ADJACENT TECHNOLOGIES
    • 5.7.3.1 Digital therapeutics
    • 5.7.3.2 Blockchain technologies
    • 5.7.3.3 Augmented reality and virtual reality
• 5.8 TARIFF & REGULATORY ANALYSIS
  • 5.8.1 TARIFF DATA ANALYSIS
    • 5.8.1.1 Average tariff for HS code 9018
    • 5.8.1.2 Average tariff for HS code 9021
    • 5.8.1.3 Average tariff for HS code 9022
  • 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8.3 REGULATORY STANDARDS
  • 5.8.4 REGULATORY REQUIREMENTS
• 5.9 TRADE ANALYSIS
  • 5.9.1 TRADE ANALYSIS FOR HSN CODE 90189099, 2019-2023
    • 5.9.1.1 Top 10 importers for HSN code 90189099
    • 5.9.1.2 Top 10 exporters for HSN code 90189099
  • 5.9.2 TRADE ANALYSIS FOR HSN CODE 9021, 2019-2023
    • 5.9.2.1 Top 10 importers for HSN code 9021
    • 5.9.2.2 Top 10 exporters for HSN code 9021
  • 5.9.3 TRADE ANALYSIS FOR HSN CODE 9022, 2019-2023
    • 5.9.3.1 Top 10 importers for HSN code 9022
    • 5.9.3.2 Top 10 exporters for HSN code 9022
• 5.10 PRICING ANALYSIS
  • 5.10.1 INDICATIVE PRICE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, BY COMPONENT, 2023
  • 5.10.2 AVERAGE PRICING TREND OF AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2022-2024
  • 5.10.3 PRICING MODELS
• 5.11 PORTER'S FIVE FORCES ANALYSIS
  • 5.11.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.11.2 THREAT OF NEW ENTRANTS
  • 5.11.3 THREAT OF SUBSTITUTES
  • 5.11.4 BARGAINING POWER OF BUYERS
  • 5.11.5 BARGAINING POWER OF SUPPLIERS
• 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.12.2 KEY BUYING CRITERIA
• 5.13 PATENT ANALYSIS
  • 5.13.1 PATENT PUBLICATION TRENDS FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
  • 5.13.2 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS
• 5.14 UNMET NEEDS & END-USER EXPECTATIONS
  • 5.14.1 UNMET NEEDS
  • 5.14.2 END-USER EXPECTATIONS
• 5.15 KEY CONFERENCES & EVENTS, 2025-2026
• 5.16 CASE STUDY ANALYSIS
  • 5.16.1 TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH CAREGILITY VIRTUAL NURSING SOLUTION
  • 5.16.2 TELADOC HEALTH TO PROVIDE MEDICARE ADVANTAGE PLAN FOR CLOSING GAPS AND BOOSTING QUALITY RATINGS
  • 5.16.3 LMH HEALTH TO REDUCE NURSE WORKLOAD WITH VIRTUAL NURSING
• 5.17 INVESTMENT & FUNDING SCENARIO
• 5.18 BUSINESS MODEL ANALYSIS
  • 5.18.1 DIRECT-TO-PATIENT (D2P) MODELS
  • 5.18.2 BUSINESS-TO-BUSINESS (B2B) MODELS
  • 5.18.3 EMPLOYER-SPONSORED MODELS
  • 5.18.4 SUBSCRIPTION-BASED MODELS
  • 5.18.5 HYBRID TELEMEDICINE MODELS
  • 5.18.6 PLATFORM-AS-A-SERVICE (PAAS) MODELS
  • 5.18.7 VALUE-BASED CARE MODELS
• 5.19 REIMBURSEMENT SCENARIO ANALYSIS

6 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT

• 6.1 INTRODUCTION
• 6.2 HARDWARE
  • 6.2.1 HIGH DEMAND FOR REMOTE PATIENT MONITORING DEVICES TO SPUR MARKET GROWTH
• 6.3 SOFTWARE
  • 6.3.1 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY
    • 6.3.1.1 EHR-centric software
      • 6.3.1.1.1 EHR-centric software to facilitate better care coordination and streamline administrative tasks
    • 6.3.1.2 Non-EHR-centric software
      • 6.3.1.2.1 Non-EHR-centric software to conduct virtual consultations and facilitate remote telehealth services
  • 6.3.2 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE
    • 6.3.2.1 Integrated software
      • 6.3.2.1.1 Better accessibility and efficiency in integrated software to revolutionize patient care
    • 6.3.2.2 Standalone software
      • 6.3.2.2.1 Flexibility and ease of usage to fuel uptake for high-quality remote patient care
  • 6.3.3 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT
    • 6.3.3.1 On-premises deployment
      • 6.3.3.1.1 On-premises deployment to enhance safety and control of inventory data
    • 6.3.3.2 Cloud-based deployment
      • 6.3.3.2.1 Cost-effectiveness and easy optimization of complex IT systems to boost market growth
• 6.4 SERVICES
  • 6.4.1 TELEHEALTH SERVICES TO REDUCE IN-PERSON CLINIC VISITS AND ENSURE BETTER TREATMENT ACCESSIBILITY FOR REMOTE AREAS

7 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION

• 7.1 INTRODUCTION
• 7.2 VIRTUAL CARE CONSULTATION
  • 7.2.1 AI-BASED VIRTUAL CARE PLANS TO AUTOMATE DOCUMENTATION AND OFFER BETTER CLINICAL DECISION SUPPORT
• 7.3 CHATBOTS & VIRTUAL ASSISTANTS
  • 7.3.1 CHATBOTS & VIRTUAL ASSISTANTS TO ENHANCE PATIENT ENGAGEMENT AND PROVIDE REAL-TIME HEALTH SUPPORT
• 7.4 REMOTE PATIENT MONITORING
  • 7.4.1 EFFECTIVE REAL-TIME DISEASE MONITORING WITHOUT IN-PATIENT VISITS TO DRIVE MARKET
• 7.5 VIRTUAL NURSING CARE PLATFORMS
  • 7.5.1 VIRTUAL NURSING PLATFORMS TO ELIMINATE NURSING SHORTAGES, REDUCE BURNOUT, AND PROVIDE HIGH-QUALITY CARE
• 7.6 CLINICAL DOCUMENTATION
  • 7.6.1 NEED FOR ACCURATE AND COMPLIANT MEDICAL RECORDS FOR VIRTUAL CONSULTATIONS TO AUGMENT MARKET GROWTH
• 7.7 ADMINISTRATIVE WORKFLOW
  • 7.7.1 EFFECTIVE RESOURCE MANAGEMENT AND OPERATIONAL EFFICIENCY TO AID MARKET GROWTH
• 7.8 ANALYTICS & REPORTING
  • 7.8.1 ADVANCED ANALYTICS & REPORTING TOOLS TO FOSTER BETTER CARE COORDINATION AND PROVIDE PERSONALIZED TREATMENTS
• 7.9 PATIENT ENGAGEMENT
  • 7.9.1 BETTER PATIENT ENGAGEMENT TO ADVANCE HEALTHCARE DELIVERY AND PROMOTE BETTER ADHERENCE TO TREATMENT PLANS
• 7.10 OTHER FUNCTIONS

8 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 PRIMARY CARE APPLICATIONS
  • 8.2.1 TECHNOLOGICAL ADVANCEMENTS AND DEMAND FOR PERSONALIZED HEALTHCARE DELIVERY TO PROPEL MARKET GROWTH
• 8.3 SPECIALTY CARE APPLICATIONS
  • 8.3.1 TELERADIOLOGY
    • 8.3.1.1 Reduced turnaround time for imaging reports and better access to radiologists in remote areas to support market growth
  • 8.3.2 TELECARDIOLOGY
    • 8.3.2.1 Real-time ECG interpretations and remote cardiac care for chronic patients to augment market growth
  • 8.3.3 TELENEUROLOGY
    • 8.3.3.1 Growing focus on advanced neurological care without in-person visits to aid market growth
  • 8.3.4 DIABETES
    • 8.3.4.1 Rising prevalence of diabetes to drive market
  • 8.3.5 RESPIRATORY DISORDERS
    • 8.3.5.1 Increasing incidence of respiratory diseases among geriatric population to propel market growth
  • 8.3.6 HYPERTENSION
    • 8.3.6.1 Need for constant monitoring and high prevalence of hypertension to boost market growth
  • 8.3.7 TELEDERMATOLOGY
    • 8.3.7.1 Increased occurrence of skin cancer to fuel market growth
  • 8.3.8 TELEPSYCHIATRY
    • 8.3.8.1 Shortage of mental health practitioners in rural areas to fuel uptake
  • 8.3.9 OTHER SPECIALTY CARE APPLICATIONS
• 8.4 TELEICU
  • 8.4.1 INCREASE IN EMERGENCY DEPARTMENT VISITS AND UNEVEN DISTRIBUTION OF ER SPECIALISTS TO PROPEL MARKET GROWTH
• 8.5 OTHER APPLICATIONS

9 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HEALTHCARE PROVIDERS
  • 9.2.1 HOSPITALS
    • 9.2.1.1 Growing incidence of chronic diseases and increasing demand for high-quality care to aid market growth
  • 9.2.2 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS
    • 9.2.2.1 Cost-effectiveness and reduced patient downtime to augment market growth
  • 9.2.3 LONG-TERM CARE & ASSISTED LIVING FACILITIES
    • 9.2.3.1 Need for prolonged treatment for chronic diseases to support market growth
  • 9.2.4 HOME HEALTHCARE
    • 9.2.4.1 Demand for cost-effective solutions and low hospital readmissions to propel segment growth
  • 9.2.5 OTHER HEALTHCARE PROVIDERS
• 9.3 HEALTHCARE PAYERS
  • 9.3.1 HEALTHCARE PAYERS TO REDUCE OVERHEAD COSTS, MINIMIZE PAPER TRAILS, AND IMPROVE MEMBER SERVICES
• 9.4 PATIENTS
  • 9.4.1 EMERGENCE OF ADVANCED WEARABLE DEVICES AND USE OF AI IN PERSONALIZED PATIENT CARE TO FUEL MARKET GROWTH
• 9.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 9.5.1 NEED FOR STREAMLINED DRUG DEVELOPMENT PROCESSES AND ENHANCED CLINICAL TRIAL PARTICIPATION TO DRIVE MARKET
• 9.6 MEDTECH COMPANIES
  • 9.6.1 MEDTECH COMPANIES TO IMPROVE DIAGNOSTIC ACCURACY AND FACILITATE PERSONALIZED TREATMENT PLANS
• 9.7 OTHER END USERS

10 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 US to dominate North American market during forecast period
  • 10.2.3 CANADA
    • 10.2.3.1 Government initiatives on digital health integration to drive adoption of telehealth and mHealth applications
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Favorable government initiatives to support market growth
  • 10.3.3 UK
    • 10.3.3.1 Growing reliance on digital healthcare platforms and increasing investments in remote mental health services to drive market
  • 10.3.4 FRANCE
    • 10.3.4.1 Favorable reimbursement for telemedicine solutions to spur market growth
  • 10.3.5 ITALY
    • 10.3.5.1 Strategic government regulations and high investments in healthcare digitalization to augment market growth
  • 10.3.6 SPAIN
    • 10.3.6.1 Rapid expansion of eHealth sector and increased adoption of wearable technologies to favor market growth
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 CHINA
    • 10.4.2.1 Increasing private sector investments in digital infrastructure to boost market growth
  • 10.4.3 JAPAN
    • 10.4.3.1 High geriatric population and strong technological infrastructure to propel market growth
  • 10.4.4 INDIA
    • 10.4.4.1 Increased government focus on digital transformation in rural areas to aid market growth
  • 10.4.5 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Increasing adoption of digital health solutions in public and private systems to aid market growth
  • 10.5.3 MEXICO
    • 10.5.3.1 Favorable regulatory scenario to fuel market growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Shortage of skilled healthcare workforce to support market growth
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN TELEHEALTH & TELEMEDICINE MARKET
• 11.3 REVENUE ANALYSIS, 2020-2024
• 11.4 MARKET SHARE ANALYSIS, 2023
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Region footprint
    • 11.5.5.3 Function footprint
    • 11.5.5.4 Application footprint
    • 11.5.5.5 Component footprint
    • 11.5.5.6 End-user footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 11.6.5.1 Detailed list of key startups/SMEs
    • 11.6.5.2 Competitive benchmarking of key startups/SMEs, by region
• 11.7 COMPANY VALUATION & FINANCIAL METRICS
  • 11.7.1 FINANCIAL METRICS
  • 11.7.2 COMPANY VALUATION
• 11.8 BRAND/SOFTWARE COMPARISON
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES & APPROVALS
  • 11.9.2 DEALS

12 COMPANY PROFILE

• 12.1 KEY PLAYERS
  • 12.1.1 MEDTRONIC
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products/Services/Solutions offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches and approvals
      • 12.1.1.3.2 Deals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Right to win
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses & competitive threats
  • 12.1.2 TELADOC HEALTH, INC.
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products/Services/Solutions offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product launches and upgrades
      • 12.1.2.3.2 Deals
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Right to win
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses & competitive threats
  • 12.1.3 KONINKLIJKE PHILIPS N.V.
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products/Services/Solutions offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product approvals
      • 12.1.3.3.2 Deals
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Right to win
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses & competitive threats
  • 12.1.4 CISCO SYSTEMS, INC.
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products/Services/Solutions offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Product launches
      • 12.1.4.3.2 Deals
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Right to win
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses & competitive threats
  • 12.1.5 GE HEALTHCARE
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products/Services/Solutions offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product launches and approvals
      • 12.1.5.3.2 Deals
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Right to win
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses & competitive threats
  • 12.1.6 EPIC SYSTEMS CORPORATION
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products/Services/Solutions offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Product launches and upgrades
      • 12.1.6.3.2 Deals
  • 12.1.7 ORACLE
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products/Services/Solutions offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Product launches
      • 12.1.7.3.2 Deals
  • 12.1.8 DOXIMITY, INC.
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products/Services/Solutions offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Product upgrades
      • 12.1.8.3.2 Deals
      • 12.1.8.3.3 Other developments
  • 12.1.9 INCLUDED HEALTH, INC.
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products/Services/Solutions offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Deals
      • 12.1.9.3.2 Other developments
  • 12.1.10 ZOOM COMMUNICATIONS, INC.
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products/Services/Solutions offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Deals
  • 12.1.11 AMERICAN WELL
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products/Services/Solutions offered
    • 12.1.11.3 Recent developments
      • 12.1.11.3.1 Product launches
      • 12.1.11.3.2 Deals
      • 12.1.11.3.3 Other developments
  • 12.1.12 SIEMENS HEALTHINEERS AG
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products/Services/Solutions offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Product approvals
  • 12.1.13 AMC HEALTH
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products/Services/Solutions offered
    • 12.1.13.3 Recent developments
      • 12.1.13.3.1 Deals
  • 12.1.14 TELESPECIALISTS
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products/Services/Solutions offered
    • 12.1.14.3 Recent developments
      • 12.1.14.3.1 Product launches
      • 12.1.14.3.2 Deals
      • 12.1.14.3.3 Other developments
  • 12.1.15 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.)
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products/Services/Solutions offered
    • 12.1.15.3 Recent developments
      • 12.1.15.3.1 Product launches
      • 12.1.15.3.2 Expansions
  • 12.1.16 CAREGILITY
    • 12.1.16.1 Business overview
    • 12.1.16.2 Products/Services/Solutions offered
    • 12.1.16.3 Recent developments
      • 12.1.16.3.1 Product launches and upgrades
      • 12.1.16.3.2 Deals
      • 12.1.16.3.3 Other developments
  • 12.1.17 CVS HEALTH
    • 12.1.17.1 Business overview
    • 12.1.17.2 Products/Services/Solutions offered
    • 12.1.17.3 Recent developments
      • 12.1.17.3.1 Product launches and upgrades
  • 12.1.18 ALIVECOR, INC.
    • 12.1.18.1 Business overview
    • 12.1.18.2 Products/Services/Solutions offered
    • 12.1.18.3 Recent developments
      • 12.1.18.3.1 Product launches and approvals
      • 12.1.18.3.2 Deals
      • 12.1.18.3.3 Other developments
  • 12.1.19 ELATION
    • 12.1.19.1 Business overview
    • 12.1.19.2 Products/Services/Solutions offered
    • 12.1.19.3 Recent developments
      • 12.1.19.3.1 Deals
  • 12.1.20 HEALTHTAP, INC.
    • 12.1.20.1 Business overview
    • 12.1.20.2 Products/Services/Solutions offered
    • 12.1.20.3 Recent developments
      • 12.1.20.3.1 Product launches
      • 12.1.20.3.2 Deals
• 12.2 OTHER PLAYERS
  • 12.2.1 CURAI HEALTH
  • 12.2.2 ANDOR HEALTH
  • 12.2.3 K HEALTH
  • 12.2.4 TRANSCARENT
  • 12.2.5 BIOINTELLISENSE, INC.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS